FlaggedRx← Medication recall checkHome
Class II · ModerateActive recall

Bupropion Hydrochloride

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot #: BPA123098A, Exp. Date 06/2025
Where it was soldNationwide within the United States
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Presence of Foreign Tablets/Capsules

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Made byGraviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA foreign manufacturer
Brand nameBUPROPION HYDROCHLORIDE
Generic nameBUPROPION HYDROCHLORIDE
Active ingredient(s)BUPROPION HYDROCHLORIDE
Distributed by / forRising Pharma Holdings, Inc. East Brunswick, NJ 08816
NDC16571-862-03
Show the full FDA record
Full product labelbuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03
Recalling firmRising Pharma Holding, Inc.
DistributionNationwide within the United States
Quantity47,976 bottles
Recall initiated2023-12-29
Report date2024-01-17
Recall completed
Recall numberD-0222-2024
ClassificationClass II
FDA statusOngoing
Origin on fileEast Brunswick NJ United States

Related

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.